Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UltraThera Technologies is a private U.S. medical device and neurorehabilitation company focused on technology-assisted treatment for balance and vestibular disorders. Its flagship product, GyroStim, is an FDA-cleared, Breakthrough Device-designated, computer-controlled multi-axis rotational chair used for multimodal neurorehabilitation and vestibular rehabilitation. The company markets GyroStim for clinical neurorehabilitation and related applications spanning concussion, traumatic brain injury, vestibular dysfunction, and broader neurological recovery. UltraThera appears to operate as a single-product/platform company built around patented robotic, software-enabled rehabilitation technology rather than a traditional drug-development pipeline. The business also provides installation, training, and support for clinics acquiring GyroStim systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UltraThera Technologies.